Authors: Clark, CA Spitzer, KA Laskin, CA

Citation: Ca. Clark et al., The spectrum of the antiphospholipid syndrome: A matter of perspective, J RHEUMATOL, 28(9), 2001, pp. 1939-1941

Authors: Clark-Soloninka, CA Laskin, CA

Citation: Ca. Clark-soloninka et Ca. Laskin, In vitro thrombin generation, J RHEUMATOL, 28(4), 2001, pp. 919-919

Authors: Bruce, IN Clark-Soloninka, CA Spitzer, KA Gladman, DD Urowitz, MB Laskin, CA

Citation: In. Bruce et al., Prevalence of antibodies to beta(2)-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: A single center study and literature review, J RHEUMATOL, 27(12), 2000, pp. 2833-2837

Authors: Douketis, JD Crowther, MA Julian, JA Stewart, K Donovan, D Kaminska, EA Laskin, CA Ginsberg, JS

Citation: Jd. Douketis et al., The effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus, THROMB HAEM, 82(3), 1999, pp. 1028-1032

Authors: Ray, JG Laskin, CA

Citation: Jg. Ray et Ca. Laskin, Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review, PLACENTA, 20(7), 1999, pp. 519-529

Authors: Clark-Soloninka, CA Spitzer, KA Laskin, CA

Citation: Ca. Clark-soloninka et al., LAC (lupus anticoagulant) - Negative results? Substrate problem?, FERT STERIL, 72(1), 1999, pp. 187-188